Objectives
Enterococcus faecalis
is a gram positive diplococci, highly versatile and a normal commensal of the gut microbiome. Resistance to vancomycin is a serious issue in various health-care setting exhibited by vancomycin resistant Enterococci (VRE) due to the alteration in the peptidoglycan synthesis pathway. This study is thus aimed to detect the VRE from the patients with root caries from the clinical isolates of
E. faecalis
and to evaluate the in-silico interactions between vanA and the
Aegles marmelos
bio-compounds.
Methods
E. faecalis
was phenotypically characterized from 20 root caries samples and the frequency of
vanA
and
vanB
genes was detected by polymerase chain reaction (PCR). Further crude methanolic extracts from the dried leaves of
A. marmelos
was assessed for its antimicrobial activity. This is followed by the selection of five
A. marmelos
bio-compounds for the computational approach towards the drug ligand interactions.
Results
12 strains (60%) of
E. faecalis
was identified from the root caries samples and
vanA
was detected from two strains (16%). Both the stains showed the presence of
vanA
and none of the strains possessed
vanB
. Crude extract of
A. marmelos
showed promising antibacterial activity against the VRE strains.
In-silico
analysis of the
A. marmelos
bio-compounds revealed Imperatonin as the best compound with high docking energy (–8.11) and hydrogen bonds with < 140 TPSA (Topological polar surface area) and zero violations.
Conclusion
The present study records the VRE strains among the root caries with imperatorin from
A. marmelos
as a promising drug candidate. However the study requires further experimentation and validation.